These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 17111473)
1. Cholesterol. Harv Mens Health Watch; 2006 Aug; 11(1):2-3. PubMed ID: 17111473 [No Abstract] [Full Text] [Related]
2. Intensive lipid lowering with atorvastatin in coronary disease. Modest GA N Engl J Med; 2005 Jul; 353(1):93-6; author reply 93-6. PubMed ID: 16003833 [No Abstract] [Full Text] [Related]
3. Achieving lipid goals. A study of outcomes in an NP Clinic. Adkins J; Stanley M Adv Nurse Pract; 2007 Jun; 15(6):61-2, 64. PubMed ID: 19999011 [No Abstract] [Full Text] [Related]
4. Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. Brunzell JD; Davidson M; Furberg CD; Goldberg RB; Howard BV; Stein JH; Witztum JL J Am Coll Cardiol; 2008 Apr; 51(15):1512-24. PubMed ID: 18402913 [No Abstract] [Full Text] [Related]
5. Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins. Barter PJ; Rye KA Circulation; 2006 Sep; 114(12):1315-20; discussion 1320. PubMed ID: 16982953 [No Abstract] [Full Text] [Related]
6. Lowering cholesterol: is there a limit? Harv Mens Health Watch; 2007 May; 11(10):5-6, 8. PubMed ID: 17514824 [No Abstract] [Full Text] [Related]
10. C-reactive protein and cholesterol are equally strong predictors of cardiovascular risk and both are important for quality clinical care. Ridker PM; Kastelein JJ; Genest J; Koenig W Eur Heart J; 2013 May; 34(17):1258-61. PubMed ID: 23376447 [No Abstract] [Full Text] [Related]
11. Are we lowering LDL cholesterol sufficiently? Barter P; Rye KA Nat Clin Pract Cardiovasc Med; 2006 Jun; 3(6):290-1. PubMed ID: 16728988 [No Abstract] [Full Text] [Related]
12. All at sea: new lipid-lowering drug trials continue to disappoint. Wierzbicki AS Int J Clin Pract; 2013 Jul; 67(7):595-8. PubMed ID: 23758438 [No Abstract] [Full Text] [Related]
13. [Reasons for a combination]. Núñez-Cortés JM Clin Investig Arterioscler; 2014 Jul; 26 Suppl 1():40-1. PubMed ID: 25043547 [No Abstract] [Full Text] [Related]
14. Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study). Cui Y; Watson DJ; Girman CJ; Shapiro DR; Gotto AM; Hiserote P; Clearfield MB Am J Cardiol; 2009 Sep; 104(6):829-34. PubMed ID: 19733719 [TBL] [Abstract][Full Text] [Related]
16. The "other revolution" in stroke prevention. Melissano G; Chiesa R Eur J Vasc Endovasc Surg; 2009 Aug; 38(2):141-2. PubMed ID: 19515588 [No Abstract] [Full Text] [Related]
17. Can statins help healthy people? Johns Hopkins Med Lett Health After 50; 2009 Mar; 21(1):1. PubMed ID: 19370796 [No Abstract] [Full Text] [Related]
18. Exaggerated benefits of rosuvastatin compared with other statins. Qizilbash N Pharmacoepidemiol Drug Saf; 2009 May; 18(5):425-6. PubMed ID: 19382149 [No Abstract] [Full Text] [Related]
19. Statin effects in CKD: is there a "point of no return"? Wanner C Am J Kidney Dis; 2009 May; 53(5):723-5. PubMed ID: 19393469 [No Abstract] [Full Text] [Related]